Profilo
Dr. David M.
Gravett is Vice President-Research & Development at Carbylan Therapeutics, Inc.
Dr. Gravett was previously employed as Vice President-Formulations & Polymer Chemistry by Angiotech Pharmaceuticals, Inc. and a Principal by Pasteur Mérieux Connaught.
He received his doctorate degree from the University of Toronto.
Precedenti posizioni note di David M. Gravett
| Società | Posizione | Fine |
|---|---|---|
Carbylan Therapeutics, Inc.
Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of molecule protease inhibitors | Direttore Tecnico/Scientifico/R&S | 15/04/2016 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices and pharmaceuticals for oncology, wound closure and ophthalmology | Corporate Officer/Principal | - |
Pasteur Mérieux Connaught | Corporate Officer/Principal | - |
Formazione di David M. Gravett
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices and pharmaceuticals for oncology, wound closure and ophthalmology | Health Technology |
Carbylan Therapeutics, Inc.
Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of molecule protease inhibitors | Health Technology |
University of Natal
University of Natal Other Consumer ServicesConsumer Services College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pasteur Mérieux Connaught |
















